Spots Global Cancer Trial Database for stage ii
Every month we try and update this database with for stage ii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
| Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery | NCT02391194 | Breast Cancer | AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
| Adjuvant Aspirin Treatment for Colon Cancer Patients | NCT02467582 | Colon Cancer | Aspirin Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Post Market Study Using the Xoft Axxent System | NCT01017549 | Breast Cancer | Electronic brac... | 50 Years - | Xoft, Inc. | |
| Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT01318642 | Adenocarcinoma ... Locally Advance... Unresectable | Gemcitabine AMG 479 Placebo | 18 Years - | Amgen | |
| The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma | NCT01187238 | Nasopharyngeal ... | cisplatin | 18 Years - 70 Years | ChineseAMS | |
| De-escalation Study for Stage IIa/IIb < 3 cm Seminoma | NCT05529251 | Seminoma Stage II | Radiotherapy bo... Carboplatin AUC... 3 cycles of EP | 18 Years - | Centre Leon Berard | |
| The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma | NCT01187238 | Nasopharyngeal ... | cisplatin | 18 Years - 70 Years | ChineseAMS | |
| Anti PD-1 Neo-adjuvant Treatment for NSCLC | NCT02938624 | Non Small Cell ... Stage I Stage II | Pembrolizumab 2... Pembrolizumab 2... Pembrolizumab 2... Pembrolizumab 1... Surgical resect... | 18 Years - 99 Years | Sheba Medical Center | |
| Cisplatin + RT for Triple Negative Breast Cancer | NCT01674842 | Breast Cancer | Radiation Thera... Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients | NCT00774839 | Colon Cancer | Patient Intervi... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients | NCT00774839 | Colon Cancer | Patient Intervi... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
| CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer | NCT00434031 | Breast Cancer | docetaxel cyclophosphamid... trastuzumab liposomal doxor... | 18 Years - 65 Years | National Cancer Institute, Naples | |
| Adjuvant PEG Intron in Ulcerated Melanoma | NCT01502696 | Ulcerated Melan... | PEG IFN alfa-2b | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Rectal Cancer Consortium | NCT01835925 | Rectal Cancer | Tissue specimen | 18 Years - | Brown University | |
| Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid | NCT00295646 | Breast Cancer | tamoxifen anastrozole zoledronic acid goserelin | 19 Years - 59 Years | Austrian Breast & Colorectal Cancer Study Group | |
| Adjuvant PEG Intron in Ulcerated Melanoma | NCT01502696 | Ulcerated Melan... | PEG IFN alfa-2b | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Post Market Study Using the Xoft Axxent System | NCT01017549 | Breast Cancer | Electronic brac... | 50 Years - | Xoft, Inc. | |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy | NCT05031975 | Colorectal Canc... | Irinotecan Temozolomide | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure | NCT03375892 | Breast Cancer Ductal Carcinom... Invasive Breast... | Deep Inspiratio... Free breathing ... | 18 Years - | Medical College of Wisconsin | |
| Rectal Cancer Consortium | NCT01835925 | Rectal Cancer | Tissue specimen | 18 Years - | Brown University | |
| Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls" | NCT03071809 | Neoplasms, Non-... | 18 Years - | Lexent Bio, Inc. | ||
| BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study | NCT02550743 | Rectal Cancer | BYL719 Capecitabine Radiation | 18 Years - | Brown University | |
| Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | NCT05174169 | Stage III Colon... | Signatera test mFOLFOX6 3-6 mo... CAPOX 3 month mFOLFIRINOX mFOLFOX6 6 mont... CAPOX 6 month | 18 Years - | NRG Oncology | |
| MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles | NCT03053193 | Breast Cancer | MammaPrint, Blu... | 18 Years - | Agendia | |
| Prebiotics in Rectal Cancer | NCT05516641 | Rectal Cancer | Soluble Corn Fi... Maltodextrin | 18 Years - | Ochsner Health System | |
| Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
| Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry | NCT02670577 | Breast Cancer | 18 Years - | Agendia | ||
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | NCT03794544 | Resectable Early-stage NSCLC | Durvalumab Oleclumab Monalizumab Danvatirsen | 18 Years - 102 Years | MedImmune LLC | |
| Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients | NCT00774839 | Colon Cancer | Patient Intervi... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
| A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy | NCT05178576 | Colon Cancer | Gevokizumab Signatera test | 18 Years - | NSABP Foundation Inc | |
| Rectal Cancer Consortium | NCT01835925 | Rectal Cancer | Tissue specimen | 18 Years - | Brown University | |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy | NCT05031975 | Colorectal Canc... | Irinotecan Temozolomide | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | NCT03794544 | Resectable Early-stage NSCLC | Durvalumab Oleclumab Monalizumab Danvatirsen | 18 Years - 102 Years | MedImmune LLC | |
| Cisplatin + RT for Triple Negative Breast Cancer | NCT01674842 | Breast Cancer | Radiation Thera... Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer | NCT02835066 | Smoking Lung Neoplasms | Integrated Fitn... Psychosocial As... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study | NCT02550743 | Rectal Cancer | BYL719 Capecitabine Radiation | 18 Years - | Brown University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
